Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Withdrawn 1

Sponsor Class

OTHER 7NIH 4NETWORK 1INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 2Plasma cell 1Other solid neoplasm 1CNS 1

Conditions

Unspecified Adult Solid Tumor, Protocol Specific 1

Interventions

Cisplatin 6Pemetrexed 5Carboplatin 4Standard of Care 3Specimen Handling 3Practice Guidelines as Topic 3Interviews as Topic 3Immunoenzyme Techniques 3Docetaxel 3raltitrexed 2Vincristine 2Trabectedin 2N-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide 2Irinotecan 2Immunohistochemistry 2Gemcitabine 2Etoposide 2Early Intervention, Educational 2Bortezomib 2AEG 35156 2temsirolimus 1sabarubicin 1pembrolizumab 1nintedanib 1halofuginone 1ascrinvacumab 1Triptorelin Pamoate 1Thrombopoietin 1Theophylline 1SB939 compound 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × temsirolimus × Other solid neoplasm × Clear all
NCT00788580 2015-03-06

S0718 Pazopanib and Temsirolimus in Treating Patients With Advanced Solid Tumors

SWOG Cancer Research Network

Phase 1 Withdrawn
Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

Data powered by HemOnc (CC BY 4.0) Colophon âš¡